Real-world study of hypertrophic cardiomyopathy
Part of Heart & circulation clinical trials.
This study follows people with hypertrophic cardiomyopathy (HCM), a condition where the heart muscle thickens, to learn more about how it affects them in real life. It may help doctors better understand and manage the condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a diagnosis of hypertrophic cardiomyopathy (HCM), meaning your heart muscle is at least 15 mm thick (or 13 mm if you have a family history or positive genetic test).
- You are willing to participate, sign a consent form, and attend follow-up visits.
- You do not have heart thickening due to other conditions like amyloidosis, Fabry disease, or severe high blood pressure.
- You do not have severe aortic stenosis (narrowing of a heart valve) or active cancer.
- You do not have a mental health condition that would interfere with the study.
- You are not currently enrolled in another clinical trial.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how hypertrophic cardiomyopathy (HCM) affects people in China in real-world settings. It may help doctors understand the condition better and improve care for patients like you.
This trial tests whether a personalized exercise program can safely improve fitness and daily activity for people with hypertrophic cardiomyopathy (a heart muscle condition). You would work with experts to build a routine that fits your needs and current health.
This study is a registry that collects information about people with hypertrophic cardiomyopathy (a condition where the heart muscle is thickened) to better understand how it affects different people and to study its genetic causes. By joining, you help researchers learn more about this condition and how it progresses.
This trial uses a special CT scan to create a 3D model of your heart's blood flow. It aims to see if this model can help doctors better predict how well treatments work for people with a thick heart muscle that blocks blood flow.
This registry collects information about people with hypertrophic cardiomyopathy (HCM) to better understand the condition and improve care. It is for patients who have a confirmed HCM diagnosis not caused by other issues.
This study uses MRI scans to re-examine people with hypertrophic cardiomyopathy (a thickening of the heart muscle) who were part of the original HCMR study. It compares different types of HCM to learn more over time.
Hear when a new Hypertrophic Cardiomyopathy (HCM) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.